The effect of neoadjuvant therapy on the 5-fluorouracil metabolic and relative enzymes of oral squamous cell carcinoma

  • Authors:
    • Tomomi Yamashita
    • Makoto Toida
    • Keizo Kato
    • Nguyen Khanh Long
    • Yasuo Miyazaki
    • Yuichiro Asaka
    • Daijiro Hatakeyama
    • Kazuhiro Yonemoto
    • Hiroki Makita
    • Yukihiro Kato
    • Toshiyuki Shibata
  • View Affiliations

  • Published online on: September 1, 2009     https://doi.org/10.3892/or_00000463
  • Pages: 501-507
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To assess the effect of neoadjuvant therapy using tegafur/uracil (UFT) and radiation therapy on the 5-fluorouracil (5-FU) metabolic and relative enzymes, thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), orotate phosphoribosyl transferase (OPRT) and thymidine phosphorylase (TP) in oral squamous cell carcinoma (OSCC), we examined the mRNA expression and immunohistochemical staining status of these enzymes using 17 surgical specimens. Seven patients did not receive any neoadjuvant therapy and 10 were treated with UFT and local irradiation therapy. Our result showed that the mRNA expression of these enzymes in neoadjuvant group was not significantly different from that of non-treated group using real-time quantitative PCR. To confirm the protein expression, we also carried out immunohistological staining of TS and DPD two key enzymes in the 5-FU metabolism, using the same specimens. Immunohistological staining status did not correspond to the results of mRNA analysis completely, though no significant difference between the groups was observed. Furthermore, no significant relationship between the UFT administration period and mRNA expression of the 5-FU metabolic enzymes was observed in neoadjuvant therapy group and also the distribution of the enzyme mRNA expression levels was similar to that of non-treated group. The results suggested that the neoadjuvant therapy of OSCC might not affect the expression status of 5-FU metabolic and relative enzymes in surgical tumor samples and the tumor tissues might serve as a useful specimen source to analyze the expression status of the 5-FU metabolic and relative enzymes and to determine the prospective efficiency of 5-FU-based adjuvant chemotherapy.

Related Articles

Journal Cover

September 2009
Volume 22 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yamashita T, Toida M, Kato K, Long NK, Miyazaki Y, Asaka Y, Hatakeyama D, Yonemoto K, Makita H, Kato Y, Kato Y, et al: The effect of neoadjuvant therapy on the 5-fluorouracil metabolic and relative enzymes of oral squamous cell carcinoma. Oncol Rep 22: 501-507, 2009.
APA
Yamashita, T., Toida, M., Kato, K., Long, N.K., Miyazaki, Y., Asaka, Y. ... Shibata, T. (2009). The effect of neoadjuvant therapy on the 5-fluorouracil metabolic and relative enzymes of oral squamous cell carcinoma. Oncology Reports, 22, 501-507. https://doi.org/10.3892/or_00000463
MLA
Yamashita, T., Toida, M., Kato, K., Long, N. K., Miyazaki, Y., Asaka, Y., Hatakeyama, D., Yonemoto, K., Makita, H., Kato, Y., Shibata, T."The effect of neoadjuvant therapy on the 5-fluorouracil metabolic and relative enzymes of oral squamous cell carcinoma". Oncology Reports 22.3 (2009): 501-507.
Chicago
Yamashita, T., Toida, M., Kato, K., Long, N. K., Miyazaki, Y., Asaka, Y., Hatakeyama, D., Yonemoto, K., Makita, H., Kato, Y., Shibata, T."The effect of neoadjuvant therapy on the 5-fluorouracil metabolic and relative enzymes of oral squamous cell carcinoma". Oncology Reports 22, no. 3 (2009): 501-507. https://doi.org/10.3892/or_00000463